Skip to main navigation Skip to search Skip to main content

A Phase 3 Randomized Double-blind Study of Adjuvant Pembrolizumab With or Without V940 in Participants With Resectable Stage II to IIIB (N2) NSCLC not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemo

    Project: Research

    Project Details

    StatusActive
    Effective start/end date07/21/25 → …